These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22768605)

  • 1. [Glucokinase activators].
    Shirakawa J; Terauchi Y
    Nihon Rinsho; 2012 May; 70 Suppl 3():721-7. PubMed ID: 22768605
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent advances in glucokinase activators for the treatment of type 2 diabetes.
    Pal M
    Drug Discov Today; 2009 Aug; 14(15-16):784-92. PubMed ID: 19520181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspects.
    Matschinsky FM; Zelent B; Doliba NM; Kaestner KH; Vanderkooi JM; Grimsby J; Berthel SJ; Sarabu R
    Handb Exp Pharmacol; 2011; (203):357-401. PubMed ID: 21484579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential role of glucokinase activator SHP289-04 in anti-diabetes and hepatic protection.
    Lei L; Liu S; Li Y; Song H; He L; Liu Q; Sun S; Li Y; Feng Z; Shen Z
    Eur J Pharmacol; 2018 May; 826():17-23. PubMed ID: 29477658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent updates on glucokinase activators for the treatment of type 2 diabetes mellitus.
    Grewal AS; Sekhon BS; Lather V
    Mini Rev Med Chem; 2014; 14(7):585-602. PubMed ID: 25052034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase.
    Kamata K; Mitsuya M; Nishimura T; Eiki J; Nagata Y
    Structure; 2004 Mar; 12(3):429-38. PubMed ID: 15016359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule glucokinase activators as glucose lowering agents: a new paradigm for diabetes therapy.
    Guertin KR; Grimsby J
    Curr Med Chem; 2006; 13(15):1839-43. PubMed ID: 16787225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of YH-GKA, a novel benzamide glucokinase activator as therapeutic candidate for type 2 diabetes mellitus.
    Park K
    Arch Pharm Res; 2012 Dec; 35(12):2029-33. PubMed ID: 23263798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of cycloalkyl-fused N-thiazol-2-yl-benzamides as tissue non-specific glucokinase activators: Design, synthesis, and biological evaluation.
    Wang Z; Shi X; Zhang H; Yu L; Cheng Y; Zhang H; Zhang H; Zhou J; Chen J; Shen X; Duan W
    Eur J Med Chem; 2017 Oct; 139():128-152. PubMed ID: 28800453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of (S)-6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid as a hepatoselective glucokinase activator clinical candidate for treating type 2 diabetes mellitus.
    Pfefferkorn JA; Guzman-Perez A; Litchfield J; Aiello R; Treadway JL; Pettersen J; Minich ML; Filipski KJ; Jones CS; Tu M; Aspnes G; Risley H; Bian J; Stevens BD; Bourassa P; D'Aquila T; Baker L; Barucci N; Robertson AS; Bourbonais F; Derksen DR; Macdougall M; Cabrera O; Chen J; Lapworth AL; Landro JA; Zavadoski WJ; Atkinson K; Haddish-Berhane N; Tan B; Yao L; Kosa RE; Varma MV; Feng B; Duignan DB; El-Kattan A; Murdande S; Liu S; Ammirati M; Knafels J; Dasilva-Jardine P; Sweet L; Liras S; Rolph TP
    J Med Chem; 2012 Feb; 55(3):1318-33. PubMed ID: 22196621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advances in the study of glucokinase and small molecule glucokinase activators].
    Li YQ; Feng ZQ; Song HR; Guo YS; Guo ZR
    Yao Xue Xue Bao; 2006 May; 41(5):390-4. PubMed ID: 16848312
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel glucokinase activators: a patent review (2008 - 2010).
    Sarabu R; Berthel SJ; Kester RF; Tilley JW
    Expert Opin Ther Pat; 2011 Jan; 21(1):13-33. PubMed ID: 21155690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy.
    Matschinsky FM; Magnuson MA; Zelent D; Jetton TL; Doliba N; Han Y; Taub R; Grimsby J
    Diabetes; 2006 Jan; 55(1):1-12. PubMed ID: 16380470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Perspective of new and future treatment of type 2 diabetes].
    Sasaoka T
    Nihon Rinsho; 2012 May; 70 Suppl 3():707-15. PubMed ID: 22768603
    [No Abstract]   [Full Text] [Related]  

  • 15. Discovery of an intravenous hepatoselective glucokinase activator for the treatment of inpatient hyperglycemia.
    Stevens BD; Litchfield J; Pfefferkorn JA; Atkinson K; Perreault C; Amor P; Bahnck K; Berliner MA; Calloway J; Carlo A; Derksen DR; Filipski KJ; Gumkowski M; Jassal C; MacDougall M; Murphy B; Nkansah P; Pettersen J; Rotter C; Zhang Y
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6588-92. PubMed ID: 24239482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyridoxine dipharmacophore derivatives as potent glucokinase activators for the treatment of type 2 diabetes mellitus.
    Dzyurkevich MS; Babkov DA; Shtyrlin NV; Mayka OY; Iksanova AG; Vassiliev PM; Balakin KV; Spasov AA; Tarasov VV; Barreto G; Shtyrlin YG; Aliev G
    Sci Rep; 2017 Nov; 7(1):16072. PubMed ID: 29167582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucokinase activators for the potential treatment of type 2 diabetes.
    Grimsby J; Berthel SJ; Sarabu R
    Curr Top Med Chem; 2008; 8(17):1524-32. PubMed ID: 19075763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons from glucokinase activators: the problem of declining efficacy.
    Agius L
    Expert Opin Ther Pat; 2014 Nov; 24(11):1155-9. PubMed ID: 25266490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tweaking the glucose sensor: adjusting glucokinase activity with activator compounds.
    Printz RL; Granner DK
    Endocrinology; 2005 Sep; 146(9):3693-5. PubMed ID: 16105828
    [No Abstract]   [Full Text] [Related]  

  • 20. Strategies for the design of hepatoselective glucokinase activators to treat type 2 diabetes.
    Pfefferkorn JA
    Expert Opin Drug Discov; 2013 Mar; 8(3):319-30. PubMed ID: 23289965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.